Cytogenetic landscape and impact in blast phase of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.
Cytogenetic landscape and impact in blast phase of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy. Leukemia. 2017 03; 31(3):585-592.
-
Adolescent
-
Adult
-
Aged
-
Aged, 80 and over
-
Antineoplastic Agents
-
Blast Crisis
-
Bone Marrow
-
Chromosome Aberrations
-
Chromosomes, Human, Pair 3
-
Female
-
Fusion Proteins, bcr-abl
-
Humans
-
Immunophenotyping
-
In Situ Hybridization, Fluorescence
-
Karyotyping
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
-
Male
-
Middle Aged
-
Molecular Targeted Therapy
-
Mutation
-
Prognosis
-
Protein Kinase Inhibitors
-
Transcription, Genetic
-
Translocation, Genetic
-
Treatment Outcome
-
Young Adult